Friday, October 10, 2014 1:13:25 PM
In order to do that, one has to understand the difference between price-based anti-dilution adjustments and stock-based anti-dilution protection. Both of which were addressed in the filing/exhibits.
Appreciate that you provided your rationale in using Section 7 of exhibit 3.1. However, this section pertains to stock based anti-dilution protection-- the nuance of referring to the price adjustment required is being incorrectly applied...
... if the company chooses to issue shares or pay cash to common shareholders (under the circumstances described in the section), then those that hold the preferreds are entitled to that same distribution. That would require a price adjustment based on stock anti-dilution protection.
There is no price-based anti dilution adjustment-- period. And a retail investor should take comfort in that fact (think toxic financiers "floor-less convertibles" or DRIO's last stock sale that had an extremely bad make whole provision)...
... however, DRIO now has roughly 45 million shares available to issue.
Duly noting that if they do issue shares, in some cases, that distribution needs to be applied to the underlying common shares of the preferred shares...
Recent DRIO News
- /C O R R E C T I O N -- DarioHealth Corp./ • PR Newswire (US) • 10/08/2024 01:09:00 PM
- National Medicare Health Plan Partners with Twill by Dario to Promote Healthy Aging with New Digital Mental Health Benefits for Seniors • PR Newswire (US) • 10/01/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 08:05:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2024 08:05:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/12/2024 08:37:42 PM
- Dario Introduces Integration of Twill Behavioral Health Capabilities into Cardiometabolic Health Solution to Enhance Member Engagement and Outcomes • PR Newswire (US) • 09/12/2024 12:30:00 PM
- Dario Publishes New Research Revealing How Physical Activity Mediates the Impact of Depression on Blood Glucose Levels in Individuals with Diabetes or Prediabetes • PR Newswire (US) • 09/10/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/10/2024 10:00:13 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/28/2024 10:12:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/23/2024 08:05:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/23/2024 08:05:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 08:01:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 08:01:15 PM
- DarioHealth Reports Second Quarter 2024 Financial and Operating Results • PR Newswire (US) • 08/08/2024 10:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 10:05:39 AM
- DarioHealth to Report Second Quarter 2024 Results on Thursday, August 8th • PR Newswire (US) • 07/30/2024 12:30:00 PM
- Dario Expands GLP-1 Solution Client Base with New Employer Contract • PR Newswire (US) • 07/16/2024 12:30:00 PM
- Dario Demonstrates 12 Months of Sustained Healthy Behavior Change for Members Taking a GLP-1 • PR Newswire (US) • 06/25/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:02:27 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:01:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 12:30:15 PM
- Empowering Commercial Expansion: DarioHealth Announces Strategic Reorganization and Appoints Inaugural Chief Commercial Officer • PR Newswire (US) • 06/05/2024 12:30:00 PM
- DarioHealth Reports First Quarter 2024 Financial and Operating Results • PR Newswire (US) • 05/15/2024 10:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 10:06:09 AM
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM